Did you know?

Axsome Therapeutics saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 8,120,000 shares, a drop of 1.5% from the previous total of 8,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting ...Consensus from 16 of the American Pharmaceuticals analysts is that Axsome Therapeutics is on the verge of breakeven. They expect the company to post a final loss in 2024, before turning a profit of US$245m in 2025. So, the company is predicted to breakeven approximately 2 years from now. In order to meet this breakeven date, we calculated the ...May 15, 2023 · Axsome Therapeutics, Inc. has come a long way since its early year as a clinical-stage innovator. The company is enjoying early launch success for its two stellar medicines (Auvelity and Sunosi).

Find real-time AXSM - Axsome Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.As a matter of fact, the issue price is at an almost 11% discount to the closing price on Jun 27, wherein the stock closed at $83.37 per share. Axsome’s shares nosedived 2.8% year to date ...Monitoring bullish and bearish sentiments towards Axsome Therapeutics on Twitter and Stocktwits could help to forecast an upward or downward trend in Axsome Therapeutics stock price. 4:00 PM (UTC) Date:29 September, 2023. 0 ...$-1.17 Reported -- Surprise -- Result N/A Quarterly Annual Historical EPS Home Symbol AXSM Earnings Checkout Axsome Therapeutics Inc (AXSM) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether AXSM beat the street expectations or not?

Axsome Therapeutics stock price target raised to $76 from $49 at Mizuho. Sep. 7, 2022 at 6:38 a.m. ET by Tomi Kilgore. In August, Axsome received FDA approval for its lead pipeline candidate AXS-05, with the trade name of Auvelity, for the treatment of adults with major depressive disorder (MDD), making it the ...3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or remove ads. AXSM Axsome Therapeutics Inc 10,958 $68.60 $1.24 (1.84%) Today $68.61 0.01 (0.01%) After Hours About Feed News Sentiment Earnings Fundamentals Upcoming EPS November 9th, 2023 Pre-Market Period Q3'23 Estimated $-1.17 Reported -- Surprise -- Result N/A ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Axsome stocktwits. Possible cause: Not clear axsome stocktwits.

Get the latest Axsome Therapeutics, Inc. (AXSM) stock news and headlines to help you in your trading and investing decisions.Oct 12, 2023 · 11 analysts have issued 1 year price objectives for Axsome Therapeutics' stock. Their AXSM share price forecasts range from $81.00 to $180.00. On average, they expect the company's share price to reach $102.40 in the next year. This suggests a possible upside of 54.0% from the stock's current price. Axsome Therapeutics Inc (AXSM) sentiment score, message volume, participation score and buzz level Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or remove ads. AXSM Axsome Therapeutics Inc 10,961 Watch Alerts $66.51 $3.68 (5.24%) Today $68.08 1.57 (2.36%) Pre-Market About Feed News Sentiment Earnings

$3.17 (4.34%) Today $69.89 0.00 (0.00%) After Hours About Feed News Sentiment Earnings Fundamentals Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.Our Mission. Our mission is to deliver innovative treatments to improve the lives of individuals with neuropsychiatric, neurologic, and other disorders to reduce the burden on patients and their caregivers.Track Netlist Inc (NLST) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

gundromeda strain Get all financial information for Axsome Therapeutics Inc (AXSM) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more. flex fence louver systemman cave garage loft In comparison to other companies in the biotechnology sector, IMGN’s stock performance on September 28, 2023, was relatively positive. CRISPR Therapeutics saw its stock price increase by +2.21%, while Axsome Therapeutics experienced a slight decline of -0.26%. Blueprint Medicines remained unchanged with a 0.00% change in its stock price.Axsome Therapeutics Options Chain & Prices (NASDAQ:AXSM) S&P 500 4,337.44. DOW 34,006.88. QQQ 359.61. 2 Must-Have Silicon Companies That Don't Make Microchips. sutherlands dodge city kansas Sync with Stocktwits. Latest AXSOME THERAPEUTICS (AXSM) stock news, Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the develo...Discover Axsome Therapeutics Inc (AXSM) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits community bloons leadtouchnet umslgreyhound track your bus il y a 1 jour ... Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits. Axsome Therapeutics logo Teacher Retirement System of Texas ...PyTwits is a REST-API Wrapper for the Social Trading Network StockTwits. Written in Python it enables the user to easily interact with StockTwits REST-API. Installation pip install PyTwits Example Usage. Following example finds AAPL symbol and prints symbol label and title. import pytwits def main (): stocktwits = pytwits. sandy sansing nissan pensacola fl $3.17 (4.34%) Today $69.89 0.00 (0.00%) After Hours About Feed News Sentiment Earnings Fundamentals Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.Axsome Therapeutics, Inc. (AXSM) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 70.19 -0.37 (-0.52%) At close: 04:00PM EDT 68.60 -1.59 (-2.27%) myaccountviewonline lpl comhow to mix permethrin 10 for humanssmiling friends meme The latest price target for Axsome Therapeutics ( NASDAQ: AXSM) was reported by Mizuho on Monday, August 28, 2023. The analyst firm set a price target for 100.00 expecting AXSM to rise to within ...Axsome Therapeutics, Inc. (. AXSM Quick Quote. AXSM - Free Report) incurred an adjusted loss of $1.28 per share in the fourth quarter of 2022, wider than the Zacks Consensus Estimate of a loss of ...